Enzymatica AB (publ)
STO:ENZY

Watchlist Manager

Enzymatica AB (publ)

STO:ENZY

Watchlist

Dividends

Discount Rate

Price: 1.8 SEK 3.45% Market Closed

Market Cap: 436.9m SEK

Have any thoughts about
Enzymatica AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 1.8 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ENZY Alert

Enzymatica AB (publ)

1.8

+0.06 (+3.45%)

52 Week Range	1.73 4.195
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Enzymatica AB (publ)

What unique competitive advantages
does Enzymatica AB (publ) hold over its rivals?

What risks and challenges
does Enzymatica AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Enzymatica AB (publ).

What unique competitive advantages
does Enzymatica AB (publ) hold over its rivals?

What risks and challenges
does Enzymatica AB (publ) face in the near future?

Has there been any significant insider trading activity
in Enzymatica AB (publ) recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Enzymatica AB (publ).

Provide P/S
for Enzymatica AB (publ).

Provide P/E
for Enzymatica AB (publ).

Provide P/OCF
for Enzymatica AB (publ).

Provide P/FCFE
for Enzymatica AB (publ).

Provide P/B
for Enzymatica AB (publ).

Provide EV/S
for Enzymatica AB (publ).

Provide EV/GP
for Enzymatica AB (publ).

Provide EV/EBITDA
for Enzymatica AB (publ).

Provide EV/EBIT
for Enzymatica AB (publ).

Provide EV/OCF
for Enzymatica AB (publ).

Provide EV/FCFF
for Enzymatica AB (publ).

Provide EV/IC
for Enzymatica AB (publ).

Show me price targets
for Enzymatica AB (publ) made by professional analysts.

What are the Revenue projections
for Enzymatica AB (publ)?

How accurate were the past Revenue estimates
for Enzymatica AB (publ)?

What are the Net Income projections
for Enzymatica AB (publ)?

How accurate were the past Net Income estimates
for Enzymatica AB (publ)?

What are the EPS projections
for Enzymatica AB (publ)?

How accurate were the past EPS estimates
for Enzymatica AB (publ)?

What are the EBIT projections
for Enzymatica AB (publ)?

How accurate were the past EBIT estimates
for Enzymatica AB (publ)?

Compare the revenue forecasts
for Enzymatica AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Enzymatica AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Enzymatica AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Enzymatica AB (publ) compared to its peers.

Compare the P/E ratios
of Enzymatica AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Enzymatica AB (publ) with its peers.

Analyze the financial leverage
of Enzymatica AB (publ) compared to its main competitors.

Show all profitability ratios
for Enzymatica AB (publ).

Provide ROE
for Enzymatica AB (publ).

Provide ROA
for Enzymatica AB (publ).

Provide ROIC
for Enzymatica AB (publ).

Provide ROCE
for Enzymatica AB (publ).

Provide Gross Margin
for Enzymatica AB (publ).

Provide Operating Margin
for Enzymatica AB (publ).

Provide Net Margin
for Enzymatica AB (publ).

Provide FCF Margin
for Enzymatica AB (publ).

Show all solvency ratios
for Enzymatica AB (publ).

Provide D/E Ratio
for Enzymatica AB (publ).

Provide D/A Ratio
for Enzymatica AB (publ).

Provide Interest Coverage Ratio
for Enzymatica AB (publ).

Provide Altman Z-Score Ratio
for Enzymatica AB (publ).

Provide Quick Ratio
for Enzymatica AB (publ).

Provide Current Ratio
for Enzymatica AB (publ).

Provide Cash Ratio
for Enzymatica AB (publ).

What is the historical Revenue growth
over the last 5 years for Enzymatica AB (publ)?

What is the historical Net Income growth
over the last 5 years for Enzymatica AB (publ)?

What is the current Free Cash Flow
of Enzymatica AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Enzymatica AB (publ).

EV/EBITDA
Enterprise Value to EBITDA

-6.5

Current

-15.1

Median

13.3

Industry

Higher than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-6.5

Enterprise Value

341.3m SEK

EBITDA

-52.1m SEK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
SE	E	Enzymatica AB (publ) STO:ENZY	436.9m SEK	-6.5
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 459 134.4
US		Eli Lilly and Co NYSE:LLY	710.5B USD	45.7
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	3 846.3
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	24.3
US		Johnson & Johnson NYSE:JNJ	373.5B USD	12.3
US		Merck & Co Inc NYSE:MRK	251.1B USD	10.5
CH		Roche Holding AG SIX:ROG	202.7B CHF	9.9
CH		Novartis AG SIX:NOVN	183.3B CHF	10.1
UK		AstraZeneca PLC LSE:AZN	162.4B GBP	169.4
IE	E	Endo International PLC LSE:0Y5F	146B USD	234.4

				EBITDA Growth
SE	E	Enzymatica AB (publ) STO:ENZY	Average EV/EBITDA: 484.8 Negative Multiple: -6.5	N/A
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 459 134.4	N/A
US		Eli Lilly and Co NYSE:LLY	45.7	195%
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	151%
DK		Novo Nordisk A/S CSE:NOVO B	24.3	84%
US		Johnson & Johnson NYSE:JNJ	12.3	14%
US		Merck & Co Inc NYSE:MRK	10.5	331%
CH		Roche Holding AG SIX:ROG	9.9	23%
CH		Novartis AG SIX:NOVN	10.1	8%
UK		AstraZeneca PLC LSE:AZN	169.4	64%
IE	E	Endo International PLC LSE:0Y5F	234.4	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

-6.3

2-Years Forward

EV/EBITDA

-6.8

3-Years Forward

EV/EBITDA

-7

Enzymatica AB (publ)
STO:ENZY

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Enzymatica AB (publ) STO:ENZY

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Enzymatica AB (publ)
STO:ENZY

EV/EBITDA
Enterprise Value to EBITDA